CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+51.63%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$2.56B
AUM Growth
+$2.56B
(+68%)
Cap. Flow
+$593M
Cap. Flow
% of AUM
23.17%
Top 10 Holdings %
Top 10 Hldgs %
67.62%
Holding
773
New
156
Increased
195
Reduced
131
Closed
143
Top Buys
| 1 |
Coinbase
COIN
|
$310M |
| 2 |
NVIDIA
NVDA
|
$182M |
| 3 |
Meta Platforms (Facebook)
META
|
$121M |
| 4 |
Protagonist Therapeutics
PTGX
|
$45.1M |
| 5 |
Apple
AAPL
|
$33.7M |
Top Sells
| 1 |
Energy Select Sector SPDR Fund
XLE
|
$33M |
| 2 |
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
|
$30.4M |
| 3 |
Immunocore
IMCR
|
$27M |
| 4 |
Imperial Oil
IMO
|
$24.7M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$23.2M |
Sector Composition
| 1 | Financials | 30.32% |
| 2 | Technology | 29.44% |
| 3 | Healthcare | 23.93% |
| 4 | Communication Services | 6.15% |
| 5 | Energy | 1.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.24T
| $675M | 26.15% | 747,212 +201,023 | +37% | +$182M |
|
|
2
Coinbase
COIN
$78.2B
| $409M | 15.83% | 1,541,904 +1,170,433 | +315% | +$310M |
|
3
Avidity Biosciences
RNA
$5.99B
| $144M | 5.56% | 5,629,103 | – | – |
|
|
4
Meta Platforms (Facebook)
META
$1.86T
| $140M | 5.41% | 287,632 +248,167 | +629% | +$121M |
|
5
PTC Therapeutics
PTCT
$3.92B
| $108M | 4.2% | 3,725,626 | – | – |
|
6
Tarsus Pharmaceuticals
TARS
$2.47B
| $77.2M | 2.99% | 2,122,530 +211,131 | +11% | +$7.67M |
|
7
Establishment Labs
ESTA
$1.2B
| $47.8M | 1.85% | 939,948 | – | – |
|
8
Stoke Therapeutics
STOK
$1.08B
| $45.4M | 1.76% | 3,365,744 -355,915 | -10% | -$4.8M |
|
|
9
Protagonist Therapeutics
PTGX
$3.67B
| $45.1M | 1.75% | +1,557,636 | New | +$45.1M |
|
|
10
Apple
AAPL
$3.45T
| $39.4M | 1.53% | 229,968 +196,456 | +586% | +$33.7M |
|
11
Fulcrum Therapeutics
FULC
$351M
| $35.1M | 1.36% | 3,713,934 +240,000 | +7% | +$2.27M |
|
12
Sumitomo Mitsui Financial
SMFG
$105B
| $33M | 1.28% | +2,800,730 | New | +$33M |
|
13
Mercer International
MERC
$223M
| $32.8M | 1.27% | 3,300,000 | – | – |
|
14
Rocket Pharmaceuticals
RCKT
$354M
| $29.6M | 1.15% | 1,100,000 | – | – |
|
|
CVII
15
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $28.4M | 1.1% | 2,652,184 -978,038 | -27% | -$10.5M |
|
16
Alibaba
BABA
$322B
| $28.2M | 1.09% | 389,543 +70,392 | +22% | +$5.09M |
|
17
Energy Transfer Partners
ET
$60.8B
| $28M | 1.08% | 1,777,000 | – | – |
|
18
UroGen Pharma
URGN
$900M
| $24.4M | 0.95% | +1,626,589 | New | +$24.4M |
|
19
SPDR S&P 500 ETF Trust
SPY
$658B
| $14.9M | 0.58% | +28,554 | New | +$14.9M |
|
|
ANSC
20
Agriculture & Natural Solutions Acquisition Corp
ANSC
$471M
| $13.6M | 0.53% | +1,335,931 | New | +$13.6M |
|
21
iShares MSCI Emerging Markets ETF
EEM
$19B
| $12.2M | 0.47% | +297,745 | New | +$12.2M |
|
22
Quanta Services
PWR
$56.3B
| $11.4M | 0.44% | +44,037 | New | +$11.4M |
|
|
RRAC
23
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $11.4M | 0.44% | 1,019,434 -157,059 | -13% | -$1.75M |
|
|
PHYT
24
DELISTED
Pyrophyte Acquisition Corp.
PHYT
| $11.1M | 0.43% | 997,063 +435,695 | +78% | +$4.85M |
|
|
SLAM
25
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $9.94M | 0.38% | 892,899 +92,899 | +12% | +$1.03M |
|